Kandasamy D, Shastry S, O'Brien S F
Department of Immunohematology & Blood Transfusion, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
Transfus Clin Biol. 2022 May;29(2):147-152. doi: 10.1016/j.tracli.2021.11.002. Epub 2021 Nov 29.
Blood donors with high Hb are often deferred for the presumed risk of polycythemia vera (PV). However, adequate data to substantiate or refute this hypothesis is lacking.
We conducted an observational study on blood donors found to have high hemoglobin (Hb≥18g/dL) during the pre-donation screening process using a portable hemoglobinometer at our blood center for four months. We adopted a cost effective methodology wherein a questionnaire was used to elicit the secondary causative factors of high hemoglobin and a complete blood count test to observe the blood cell parameters and JAK2V617F mutation test was performed in a subset of donors lacking secondary erythrocytosis (SE) history.
Of the total 7076 donors enrolled, 112 male donors (1.58%) had high hemoglobin. The majority (70.4%) were repeat donors with mean age of 31.4 years. About 61% of the donors had attributable factors for SE like smoking, occupational exposure to carbon monoxide. The mean hemoglobin value of capillary and venous hemoglobin demonstrated a statistically significant difference (P<0.05) where 2.7% of donors had venous Hb<18g/dL. The hematological profile of all the donors showed increased RBC but normal platelet and WBC count. Of 24 donors included for the JAK2V617F test, none had a positive report.
This study suggests high hemoglobin in blood donors is less likely due to PV. Hence, re-considering their deferral may help alleviate donor anxiety and allow donor return. However, multi-centric studies are required to develop consensus statements on PV risk status and blood donation eligibility.
血红蛋白(Hb)水平高的献血者常因疑似真性红细胞增多症(PV)风险而被推迟献血。然而,缺乏足够的数据来证实或反驳这一假设。
我们对在我们血液中心进行了四个月的献血前筛查过程中使用便携式血红蛋白仪发现血红蛋白高(Hb≥18g/dL)的献血者进行了一项观察性研究。我们采用了一种具有成本效益的方法,其中使用问卷来引出血红蛋白升高的次要致病因素,并进行全血细胞计数测试以观察血细胞参数,对缺乏继发性红细胞增多症(SE)病史的一部分献血者进行JAK2V617F突变测试。
在总共登记的7076名献血者中,112名男性献血者(1.58%)血红蛋白高。大多数(70.4%)是重复献血者,平均年龄为31.4岁。约61%的献血者有SE的归因因素,如吸烟、职业性一氧化碳暴露。毛细血管血红蛋白和静脉血红蛋白的平均值显示出统计学上的显著差异(P<0.05),其中2.7%的献血者静脉Hb<18g/dL。所有献血者的血液学特征显示红细胞增多,但血小板和白细胞计数正常。在纳入JAK2V617F测试的24名献血者中,没有人检测报告呈阳性。
本研究表明,献血者血红蛋白高不太可能是由于PV。因此,重新考虑推迟他们献血可能有助于减轻献血者的焦虑并允许他们再次献血。然而,需要进行多中心研究以就PV风险状况和献血资格制定共识声明。